PRODUCT INFORMATION
Description
The Cys-SP94 peptide (Ser-Phe-Ser-Ile-Ile-His-Thr-Pro-Ile-Leu-Pro-Leu-Gly-Gly-Cys) is a cysteine-conjugated ligand that targets hepatocellular carcinoma (HCC) cell lines. It serves as a key component in synthesizing stimuli-responsive nanomaterials. By selectively binding to HCC surface biomarkers in vitro, it enhances cellular internalization, demonstrating its utility for precision-targeted molecular delivery systems in preclinical oncology research.
Molecular Weight
1554.85
Purity
> 95%
Formula
C₇₂H₁₁₅N₁₇O₁₉S
Product Type
Targeting Peptide
Sequence
Ser-Phe-Ser-Ile-Ile-His-Thr-Pro-Ile-Leu-Pro-Leu-Gly-Gly-Cys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
- Pep2 Targeting Peptide (CAT#: OLY-1025-YS-41)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.